SN
Sean P. Nolan
Chief Executive Officer

Sean P. Nolan insider trades: Taysha Gene Therapies (TSHA) stock buys and sales

Chief Executive Officer, Taysha Gene Therapies Last trade Jan 26, 2026 41 Form 4 filings
$840K
Sold, last 12 months
1 sale
$0
Bought, last 12 months
0 buys
10
Open-market trades
since 2014
6
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Sean reports to the SEC

Open-market buys and sales

10 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jan 26, 2026TSHA↓ Sell$840K
Aug 16, 2023TSHA↑ Buy$400K
May 20, 2021TSHA↑ Buy$26K
Mar 7, 2018AVXS↓ Sell$1.3M
Aug 13, 2014ITMN↓ Sell$850K
Jun 18, 2014ITMN↓ Sell$471K
Jun 13, 2014ITMN↓ Sell$856K
Jun 3, 2014ITMN↓ Sell$15K
May 19, 2014ITMN↓ Sell$296K
May 8, 2014ITMN↓ Sell$95K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other TSHA insiders

Open-market trades in the last 12 months

About Sean P. Nolan's insider trades

Sean P. Nolan is Chief Executive Officer at Taysha Gene Therapies (TSHA). Since May 8, 2014, Sean has reported 2 open-market purchases worth $426K and 8 sales worth $4.7M on SEC Form 4. In the last 12 months: 1 sale ($840K).

Their filings also include grants and awards (28 filings), option exercises (5 filings), shares returned to the company (3 filings), conversions (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every TSHA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.